The influence of plasma cor ticosterone concentration on serotonin (5-HT) turnover in the dorsal hippocampus was investigated. The experiments were performed in freely moving male Wistar rats in their home cage. Blood samples were taken via a permanent jugular vein catheter to determine plasma corticosterone levels. Extracellular levels of 5-HT and its metabolite 5-hydroxy-indole acetic acid (5-HIAA) were measured using in vivo microdialysis. The rats received an intravenous (i.v.) infusion of the steroid synthesis-inhibitor metyrapone (150 mg/kg/ml) in order to manipulate circulating corticosterone levels. Three hours later, the monoamine oxidase inhibitor pargyline (15 mg/kg/2 ml i.v.) was administered to produce an accumulation of extracellular 5-HT. Pargyline administration led to a four fold increase in 5-HT levels, while reducing 5-HIAA by 45%. Metyrapone pretreatment blocked the pargyline-induced rise in plasma corticosterone to baseline levels and diminished the pargyline-induced increase in 5-HT, without affecting 5-HIAA levels. Thus, the data suggest that a decrease in availability of corticosterone for its receptors by metyrapone diminished the 5-HT synthesis rate. Since plasma corticosterone levels during this blockade are still low, it is assumed that brain glucocorticoid receptor occupation is reduced, while mineralocorticoid receptors are still substantially occupied. Therefore the present results support the hypothesis that corticosterone through glucocorticoid receptor activation enhances 5-HT synthesis rate and release in the dorsal hippocampus.
Mutual interactions between corticosteroid hormones and the 5-HT turnover as measured by in vivo microdialysis. Extracellular 5-HT and 5-HIAA levels were measured in the dorsal hippocamserotonergic ( 5-HT) system in the brain have been documented pus after administration of the MAO inhibitor pargyline (12, 13 ) . (1, 2). In the present study we focus on the raphe-dorsal
In this setup the extracellular 5-HT is a resultant from its synthesis hippocampal 5-HT system ( 3). Several studies have shown that rate and release and can be considered as an index for 5-HT corticosteroid hormones control the activity of this system. It was turnover. The 11 b-hydroxylase inhibitor, metyrapone, was used found that high amounts of corticosteroid facilitate the stress to inhibit corticosterone synthesis and consequently change the induced synthesis rate of 5-HT by increasing the catalytic efficiavailability of circulating corticosterone levels for neural corticosency of tryptophan hydroxylase (4-8 ). Additionally, 5-HT synteroid receptors (14 ) . Blood samples were taken for corticosterone thesis rate was reduced after removal of the adrenals (9) . measurement via a permanent catheter. The present findings Replacement of the adrenalectomized (ADX ) rats with corticosprovide additional evidence for the hypothesis that glucocorticoids terone restored this index for 5-HT turnover, while administration are important modulators of 5-HT transmission. of aldosterone was ineffective (10, 11) . These findings suggested that 5-HT biosynthesis is under the stringent control of the naturally occurring glucocorticoid.
Results
The above described effects of corticosteroid hormones were derived from tissue concentrations of 5-HT, in response to a
The dialysate 5-HT and 5-HIAA values were expressed as the monoamine oxidase ( MAO) inhibitor. In the present study, we percentage of the baseline prior to pargyline infusion. Baseline investigated in intact freely moving animals the dynamic relationconcentrations of 5-HT in the dialysate were 21.2±3.4 pg/ml and 35.2±8.1 pg/ml and of 5-HIAA 14.1±1.6 ng/ml and ship between the level of circulating plasma corticosterone and tophan levels, and stimulate the uptake of L-[3H ]-tryptophan by hydroxylase is also necessary for the formation of aldosterone and other 11-b hydroxylated metabolites, the concentration of brain synaptosomes (23, 24) .
Second, corticosterone modulates the excitability of hippocamthese substances will also be affected by metyrapone (e.g. aldosterone levels will decrease). Part of the diminished mineralocortpal neurons. In the hippocampus slice in vitro, the postsynaptic 5-HT 1A receptor-mediated hyperpolarization response of CA1 icoid action of aldosterone may however be compensated by increased desoxycorticosterone levels ( 35) . Further experiments pyramidal neurons is blocked by low doses of corticosterone acting predominantly on MRs. Higher levels of corticosterone are planned using GR antagonists and MR antagonists to address the matter of specificity. reverse this MR-mediated inhibition by activation of colocalized GRs. Thus, low doses of corticosterone maintain cellular excitabil-
The present findings may be important for understanding the mechanisms involved in the pathophysiology of stress and anxiety ity, whereas high corticosterone levels reduce cellular excitability in the hippocampus (2, [25] [26] [27] .
disorders. Stressful stimuli enhance the activity of tryptophan hydroxylase (6), increase brain 5-HT turnover and extracellular Third, corticosteroids may via hippocampal MRs or GRs downregulate postsynaptic 5-HT 1A receptors. After shortterm 5-HT levels (36, 37) . Reduction of 5-HT neurotransmission is regarded to have an anxiolytic effect ( 38, 39 ) . Recently, we have ADX, both 5-HT 1A mRNA hybridization and 5-HT 1A receptor radioligand binding are increased in CA1 and dentate gyrus of shown that a specific 5-HT 1A receptor agonist, R-(+)-8-OSO 2 CF 3 -PAT, reduced fear-enhanced behavior in the elevated-plus maze the hippocampus. Low doses of corticosterone or aldosterone reverse these effects of ADX and strongly suggest the involvement and concomitantly reduced 5-HT turnover in dorsal hippocampus, lateral septum and cortex ( 40) . It has been suggested that the of MRs (28) (29) (30) (31) . In contrast, ADX exerts only minor, but opposite effects on 5-HT 1A autoreceptors in the dorsal raphe anxiolytic effects of 5-HT 1A receptor agonists require action at the level of the dorsal raphe nucleus, through the stimulation of nucleus ( 31, 32) . In longterm (2 month) ADX animals, however, GR-occupancy by dexamethasone prevented a decrease in dentate somatodendritic 5-HT 1A autoreceptors resulting in a decreased firing of serotonergic neurons and a subsequent reduction in gyrus 5-HT 1A receptor mRNA, suggesting an additional role of GRs (33 ) .
5-HT release (39). Corley and colleagues (41 ) demonstrated that the anxiolytic compound gepirone, another 5-HT 1A receptor Fourth, corticosteroids via GRs in the raphe nuclei (34 ) , promote the catalytic efficiency of tryptophan hydroxylase, and agonist, administered into the dorsal raphe nucleus diminished noise stress induced increases in tryptophan hydroxylase activity. thus the synthesis of 5-HT and consequently its release in terminal areas. An increase in tryptophan hydroxylase activity has been Recently we have shown that both metyrapone (Roozendaal et al. unpublished results) and the glucocorticoid receptor antagonist, observed after exposure to different stressors, e.g. foot shock, ether anesthesia, cold exposure and noise stress (5, 7 ). This RU38486, reduce fear-enhanced anxiety behavior in the elevated plus-maze (42) . These anxiolytic actions may also be due to a increase in enzyme activity can be blocked by ADX, hypophysectomy or intracranial administration of the GR antagonist reduction of 5-HT neurotransmission. It is hypothesized that metyrapone, GR antagonists and 5-HT 1A receptor agonists exert RU38486 (7, 8 ), but not by the MR antagonist RU26752 (8) . Additionally, glucocorticoid treatment is able to restore an ADX their anxiolytic action via a common pathway, i.e., inhibition of tryptophan hydroxylase activity and 5-HT synthesis in the dorsal mediated reduction of tryptophan hydroxylase activity in cortex and midbrain ( 4, 6). This rise in enzyme activity may be due to raphe nucleus, resulting in diminished extracellular 5-HT levels in limbic forebrain areas, e.g., dorsal hippocampus. an increase in both the catalytic efficiency and the amount of the enzyme (4-7, 34).
In conclusion, the present findings support the hypothesis that high circulating corticosteroid levels stimulate 5-HT turnover. In the present study, metyrapone pretreatment prevented the pargyline-induced corticosterone increase, without affecting base-5-HT is then available in increased quantities to supply an increased demand at the synaptic endings resulting from e.g. line levels of corticosterone (control: 40 mg/100 ml; metyrapone: 8 mg/100ml). With this difference in plasma corticosterone concenstress. Additionally, chronically elevated corticosteroid levels lead to impaired 5-HT receptor mediated responses (43) (44) (45) (46) . tration GR occupancy is expected to vary from about 90% to 25% respectively. At these corticosterone levels no difference in Altogether these glucocorticoid-serotonin interactions may be of particular importance for the pathophysiology of stress and MR occupancy is expected (17) . In addition GRs, but not MRs have been shown to be present in the raphe nuclei ( 17) . Therefore anxiety disorders. it is speculated that the present findings result from a diminished GR occupancy in the raphe nuclei. Since the effects of corticos-
Materials and methods
teroids on neuronal function are conditional ( 2), the functional reconfiguration of the central nervous system induced by pargyline (48)). The microdialysis guide and the hydroxylated steroids from desoxycorticosterone ( 14) . 
